FIELD: pharmaceutical composition in form of tablet, sachet or powder for suspension.
SUBSTANCE: claimed composition contains particles of azithromicine non-dehydrated form obtained by dry granulation method and optionally one or more pharmaceutically acceptable excipient. Pharmaceutical composition preferably represents tablet containing approximately 40-85 mass % non-dehydrated azithromicine. More preferably pharmaceutical composition contains non-dehydrated azithromicine selected from F, G, J, M forms or mixtures thereof. Most preferably pharmaceutical composition contains azithromicine (A) in dose of 250 mgA, 500 mgA, 600 mgA, or 1000 mgA. Also disclosed is azithromicine particles obtained by dry granulation method that containing azithromicine form selected from F, G, J, M forms and mixtures of non-dehydrated forms, and at least one pharmaceutically acceptable excipient.
EFFECT: new azithromicine compositions.
17 cl, 7 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR AZITROMICINE WET GRANULATION | 2002 |
|
RU2283651C2 |
| DIRECT PRESSABLE AZITHROMICINE-CONTAINING FORMULATIONS | 2002 |
|
RU2277914C2 |
| PHARMACEUTICAL FORMULATION OF ATORVASTATIN | 2004 |
|
RU2325903C2 |
| SOLID DOSAGE FORMS OF PALLBOCYCLOB | 2016 |
|
RU2686840C1 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING 5,8,14-TRIAZATETRACYCLO[10,3,1,0(2,11),0(4,9)HEXADECA-2( 11),3,5,7,9-PENTAENE | 2002 |
|
RU2272629C2 |
| METHOD OF PREPARATION OF HARD MEDICINAL FORM OF DESMOPRESSIN | 2004 |
|
RU2334505C2 |
| STABLE PERORAL SUSPENSION OF NON-DIHYDRATED AZYTROMICINA | 2004 |
|
RU2325149C2 |
| DESMOPRESSIN PHARMACEUTICAL COMPOSITION AS SOLID DOSED MEDICINAL FORMULATION AND METHOD FOR ITS PREPARING | 2004 |
|
RU2303439C2 |
| TIBOLON-STABILIZING COMPOSITIONS | 1998 |
|
RU2207133C2 |
| MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
